Patents by Inventor Michael Windahl

Michael Windahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220364133
    Abstract: The present invention relates to cellobiohydrolase variants and carbohydrate binding module variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: July 13, 2022
    Publication date: November 17, 2022
    Applicant: Novozymes A/S
    Inventors: Peter Westh, Kim Borch, Trine Soerensen, Michael Windahl, Brett McBrayer
  • Patent number: 11390898
    Abstract: The present invention relates to cellobiohydrolase variants and carbohydrate binding module variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: July 19, 2022
    Assignee: Novozymes A/S
    Inventors: Peter Westh, Kim Borch, Trine Soerensen, Michael Windahl, Brett McBrayer
  • Patent number: 10676769
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: June 9, 2020
    Assignee: Novozymes A/S
    Inventors: Peter Westh, Kim Borch, Trine Soerensen, Michael Windahl, Brett McBrayer
  • Patent number: 10221406
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: March 5, 2019
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Kim Borch, Kenneth Jensen, Kristian Krogh, Brett McBrayer, Peter Westh, Jeppe Kari, Johan Olsen, Trine Sorensen, Michael Windahl, Hui Xu
  • Publication number: 20170292136
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 8, 2015
    Publication date: October 12, 2017
    Inventors: Peter Westh, Kim Borch, Trine Soerensen, Michael Windahl, Brett McBrayer
  • Publication number: 20170283843
    Abstract: The present invention relates to cellobiohydrolase variants and carbohydrate binding module variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 4, 2015
    Publication date: October 5, 2017
    Inventors: Peter Westh, Kim Borch, Trine Soerensen, Michael Windahl, Brett McBrayer
  • Publication number: 20160046917
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 7, 2014
    Publication date: February 18, 2016
    Inventors: Kim Borch, Kenneth Jensen, Kristian Krogh, Brett McBrayer, Peter Westh, Jeppe Kari, Johan Olsen, Trine Sorensen, Michael Windahl, Hui Xu